ADA Scientific Sessions 2026 Abstract
Early Real-World Liver Biomarker Changes among Resmetirom-Treated MASH Patients, with and without Concomitant GLP-1 Use: A Descriptive Cohort Study
Study in peopleInterventions
Papers by Karin Keren
1 result
1 result